Who owns CNS PHARMACEUTICALS INC?
- Ticker: CNSP
- CUSIP Number: 18978h201
Tip: Access positions for across all investors
Analyze quarterly positions in Cns Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Cns Pharmaceuticals stock
Who bought or sold CNS PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Armistice Capital | 471k | $171k | 100% | Mar 2024 |
|
Citadel Advisors | 91k | $33k | 100% | Mar 2024 |
|
Smith Anglin Financial | 90k | $33k | 81% | Mar 2024 |
|
Vanguard Group | 58k | $21k | 0% | Mar 2024 |
|
Geode Capital Management | 28k | $10k | 16% | Mar 2024 |
|
Jane Street | 27k | $9.9k | 100% | Mar 2024 |
|
Hrt Financial | 22k | $7.0k | 100% | Mar 2024 |
|
Two Sigma Securities | 22k | $7.9k | 100% | Mar 2024 |
|
XTX Topco | 19k | $6.8k | 100% | Mar 2024 |
|
Virtu Financial | 13k | $17k | 100% | Dec 2023 |
|
Tower Research Capital | 6.8k | $2.5k | 43% | Mar 2024 |
|
Bank of America Corporation | 779.00 | $0 | 77800% | Mar 2024 |
|
Wells Fargo & Company | 241.00 | $87.627600 | 16% | Mar 2024 |
|
Morgan Stanley | 67.00 | $23.999400 | 0% | Mar 2024 |
|
Global Retirement Partners | 53.00 | $19.000500 | 0% | Mar 2024 |
|
FMR | 14.00 | $4.999400 | 100% | Mar 2024 |
|
Plante Moran Financial Advisors | 1.00 | $0 | 0% | Mar 2024 |
|
Who sold out of Cns Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Susquehanna International | Sep 2023 | 21k | $24k |